Implantable Defibrillators
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Implantable</strong><br />
<strong>Defibrillators</strong><br />
Market<br />
Opportunities and<br />
Forecasts, 2014- 2022
<strong>Implantable</strong> <strong>Defibrillators</strong> Market: Future and<br />
Growth<br />
• <strong>Implantable</strong> <strong>Defibrillators</strong> Market was valued at $6,006 million<br />
in 2015 and is expected to garner $8,449 million by 2022<br />
• Registering a CAGR of 4.9% during the forecast period 2016 –<br />
2022<br />
• Transvenous implantable cardioverter defibrillators (T-ICDs)<br />
segment accounted for more than half of the global market in<br />
2015.<br />
• CRT-D is projected to lead the market, reaching 1,127 thousand<br />
units by 2022, registering a CAGR of 8.9%
<strong>Implantable</strong> <strong>Defibrillators</strong> Market: Factors<br />
Contributing to Market Growth<br />
• Surge in geriatric population; increase in prevalence of chronic<br />
health conditions such as cardiac arrhythmia, ventricular<br />
fibrillation, and pulseless ventricular tachycardia, growth in<br />
preference for S-ICDs<br />
• Rise in awareness among patients about implantable<br />
defibrillators<br />
• Rise in demand for ICDs for patients with nonischemic<br />
cardiomyopathy reduces the risk of mortality to about 23%<br />
• Emergence of new technologies
<strong>Implantable</strong> <strong>Defibrillators</strong> Market: Key Factors<br />
• In 2015, T-ICDs led the overall implantable defibrillator market<br />
revenue, and is projected to grow at a CAGR of 4.9% during the<br />
forecast period.<br />
• The CRT-D segment occupied the highest share in 2015, and is<br />
expected to grow at a CAGR of 8.9%, in terms of volume.<br />
• North America was the leading consumer of implantable<br />
defibrillators in 2015, both in terms of value and volume,<br />
followed by Europe.<br />
• Japan is expected to lead market in the Asia-Pacific region,<br />
growing at a CAGR 6.2%.
<strong>Implantable</strong> <strong>Defibrillators</strong>: Segmentation of<br />
the Market<br />
By Product Type<br />
Subcutaneous <strong>Implantable</strong> Cardioverter<br />
<strong>Defibrillators</strong> (S-ICDS)<br />
Transvenous <strong>Implantable</strong> Cardioverter-<br />
Defibrillator (T-ICDs)<br />
Cardiac Resynchronization Therapy<br />
Defibrillator (CRT-D)
<strong>Implantable</strong> <strong>Defibrillators</strong>: Segmentation of<br />
the Market<br />
• North America led the global market in 2015, and is expected<br />
to maintain its dominance during the forecast period.<br />
• Japan is expected to lead market in the Asia-Pacific region<br />
• The other regions generating revenue for the market are:<br />
Europe and LAMEA regions
<strong>Implantable</strong> <strong>Defibrillators</strong> Market: Key Players<br />
Key Players of the Market are:<br />
• Boston Scientific Corporation<br />
• LivaNova PLC Company<br />
• Imricor Medical Systems<br />
• MicroPort Scientific Corporation<br />
• Mayo Clinic US<br />
• Medtronic plc<br />
• MRI Interventions<br />
• Inc., St. Jude Medical<br />
• Inc., Biotronik Se<br />
• Co.KG, and Sorin Group.
Summary:<br />
Rise in the incidence of heart disorders and advancement in the<br />
technology such as S-ICDs developed as an alternative to<br />
conventional T-ICDs with less potential hazards drive the market<br />
growth.<br />
To know more about <strong>Implantable</strong> <strong>Defibrillators</strong> Market, visit:<br />
https://www.alliedmarketresearch.com/implantable-defibrillators-market<br />
Follow us on:
Change language